JANUS HENDERSON GROUP PLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,309,421
+5.7%
426,940
-0.2%
0.01%
+10.0%
Q2 2023$15,436,914
-5.6%
427,971
-0.0%
0.01%
-9.1%
Q1 2023$16,346,825
-55.4%
428,064
-33.5%
0.01%
-57.7%
Q4 2022$36,651,336
+34.3%
644,142
-53.3%
0.03%
+30.0%
Q3 2022$27,292,265
-9.8%
1,379,072
+100.4%
0.02%
-4.8%
Q2 2022$30,274,000
+4.0%
688,040
-5.7%
0.02%
+50.0%
Q1 2022$29,103,000
+7.8%
729,775
+8.7%
0.01%
+27.3%
Q4 2021$27,004,000
+0.8%
671,571
+2.0%
0.01%
-8.3%
Q3 2021$26,784,000
-9.5%
658,395
+1.0%
0.01%
-7.7%
Q2 2021$29,601,000
+3.9%
651,856
-4.6%
0.01%0.0%
Q1 2021$28,481,000
-16.6%
683,169
-14.5%
0.01%
-18.8%
Q4 2020$34,143,000
+46.1%
799,410
-10.1%
0.02%
+33.3%
Q3 2020$23,371,000889,3030.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders